John Feigert, M.D.

VCS Physicians

John Feigert, M.D. Headshot

What an exciting time to be treating cancer patients! The advances in treatment over the past few years now generate tremendous optimism that you can see on our patient’s faces.

Primary Location:

Arlington Office
Position

Medical Oncologist

Board Certification

Medical Oncology, Hematology and Internal Medicine

Fellowship

New York Hospital/Cornell University Medical College, Medical Oncology and Hematology

Internship

New York Hospital/Cornell University Medical College

Residency

New York Hospital/Cornell University Medical College

Medical School

Cornell University School of Medicine

College

Harvard College

With a specific interest in teaching, Dr. Feigert has held several instructional positions throughout his career. After earning his Medical Degree from the Cornell University School of Medicine, he spent a year as an Instructor of Medicine at the Cornell University Medical College and another year as the Medical Director of the Division of Oncology at Elliot Hospital in Manchester, New Hampshire. Dr. Feigert has also served as a Clinical Assistant Professor at Georgetown University Medical Center and at the Virginia Commonwealth University’s INOVA Fairfax campus.

Dr. Feigert has been recognized as a Top Doctor in both Northern Virginia Magazine and Washingtonian magazine. He has also been recognized by the Alpha Omega Alpha Honor Medical Society. Dr. Feigert is a member of several professional organizations including the American Society of Clinical Oncology, the American Society of Hematology and the Arlington County Medical Society. He is actively involved in local tumor boards, and he supports international communities through his participation with the Virginia Hospital Center Medical Brigade, a volunteer organization that helps bring clean water and health care to areas in Honduras.

During his spare time, Dr. Feigert is an active tennis player.


 

Physician Publications

October 1, 2015

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.

Read More
June 10, 2012

Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion-Dependent Patients with Myelodysplastic Syndrome.

Read More
March 1, 2010

Oncologists’ Experience in Reporting Cancer Staging and Guideline Adherence: Lessons From the 2006 Medicare Oncology Demonstration.

Read More

More Publications by John Feigert, M.D.

November 1, 2009

Two-Year Analysis of Efficacy and Safety of Deferasirox (Exjade®) Treatment in Myelodysplastic Syndrome Patients Enrolled in the US03 Study.

Read More
November 1, 2008

Iron Chelation with Deferasirox (Exjade®) Improves Iron Burden in Patients with Myelodysplastic Syndromes (MDS)

Read More
November 16, 2007

Deferasirox (ICL670; Exjade) Reduces Serum Ferritin and Labile Plasma Iron in Patients with Myelodsyplastic Syndromes.

Read More
January 1, 1998

A Comparison of Efficacy of Sargramostim (yeast-derived Rhu GM-CSF) and Filgrastim (Bacteria-derived Rhu G-CSF) in the Therapeutic Setting of Chemotherapy-induced Myelosuppression.

Read More
July 1, 1997

Randomized Trial Comparing the Tolerability of Sargramostim (yeast-derived RhuGM-CSF) and Filgrastrim (Bacteria-derived RhuG-CSF) in Cancer Patients Receiving Myelosuppressive Chemotherapy.

Read More
September 1, 1996

Rapidly Progressive Prostate Cancer in the Primary Care Setting.

Read More
January 1, 1990

Multicentric Angiofollicular Lymph Node Hyperplasia with Peripheral Neuropathy, Pseudotumor Cerebri, IgA Dysproteinemia, and Thrombocytosis in Women: A Distinct Clinicopathology Entity.

Read More
January 1, 1988

Tissue Plasminogen Activator Binds to Immobilized Immunoglobulin G: Enhancement by Plasmin and the Identification of Plasmin Derived Fab as the t-PA Binding Fragment.

Read More
January 30, 1987

Porcine Factor VIII Controls Severe Bleeding in Acquired Von Willebrand's Disease By Supplying Von Willebrand's Factor.

Read More

Primary Location

Arlington Office Office

Arlington Office

Learn More

Other Locations

Awards

November 15, 2018
Virginia Living Magazine Top Doctors 2018

Top Doctors Virginia Living Magazine 2018


January 1, 2018
Northern Virginia Magaine Top Doctor 2018

Northern Virginia Magazine Top Doctors 2018


September 9, 2016
Washingtonian Magazine

Washingtonian Top Doctor 2016


September 1, 2015
Washingtonian Magazine

Washingtonian Top Doctor 2015


February 1, 2015
Northern Virginia Magazine

Top Doctor 2015


January 31, 2014
Northern Virginia Magazine

Top Doctor 2014


December 31, 2013
Washingtonian Magazine

Top Doctor 2014